Though relatively fewer studies on another two HBP genes, GNPNAT1 and PGM3, the overexpression of GNPNAT1 and PGM3 was reported in lung adenocarcinoma and prostate cancer, respectively (Munkley et al., 2016; Liu et al., 2021). This evidence concerns the gene GNPNAT1 and prostate carcinoma.